ArticleCase reports in oncology

Pembrolizumab-Induced Immune-Mediated Colitis in a Patient with Concurrent Clostridium Difficile Infection.

Cheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.